title: Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance.
abstract: The present investigation was undertaken to test whether exercise training (ET) associated with AMPK/PPAR agonists (EM) would improve skeletal muscle function in mdx mice. These drugs have the potential to improve oxidative metabolism. This is of particular interest because oxidative muscle fibers are less affected in the course of the disease than glycolitic counterparts. Therefore, a cohort of 34 male congenic C57Bl/10J mdx mice included in this study was randomly assigned into four groups: vehicle solution (V), EM [AICAR (AMPK agonist, 50 mg/Kg-1.day-1, ip) and GW 1516 (PPARδ agonist, 2.5 mg/Kg-1.day-1, gavage)], ET (voluntary running on activity wheel) and EM+ET. Functional performance (grip meter and rotarod), aerobic capacity (running test), muscle histopathology, serum creatine kinase (CK), levels of ubiquitined proteins, oxidative metabolism protein expression (AMPK, PPAR, myoglobin and SCD) and intracellular calcium handling (DHPR, SERCA and NCX) protein expression were analyzed. Treatments started when the animals were two months old and were maintained for one month. A significant functional improvement (p<0.05) was observed in animals submitted to the combination of ET and EM. CK levels were decreased and the expression of proteins related to oxidative metabolism was increased in this group. There were no differences among the groups in the intracellular calcium handling protein expression. To our knowledge, this is the first study that tested the association of ET with EM in an experimental model of muscular dystrophy. Our results suggest that the association of ET and EM should be further tested as a potential therapeutic approach in muscular dystrophies.
authors.affiliation: Human Genome Research Center - Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil.
authors.forename: Carlos R
authors.initials: CR
authors.lastname: Bueno Júnior
authors.forename: Lucas C
authors.initials: LC
authors.lastname: Pantaleão
authors.forename: Vanessa A
authors.initials: VA
authors.lastname: Voltarelli
authors.forename: Luiz Henrique M
authors.initials: LH
authors.lastname: Bozi
authors.forename: Patricia Chakur
authors.initials: PC
authors.lastname: Brum
authors.forename: Mayana
authors.initials: M
authors.lastname: Zatz
mesh_terms: D000263:Adenylate Kinase / Q000187:drug effects*; D000273:Adipose Tissue; D000818:Animals; D002118:Calcium / Q000378:metabolism; D007677:Kidney Function Tests; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018101:Mice, Inbred mdx; D009124:Muscle Proteins / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D010084:Oxidation-Reduction; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists*; D010805:Physical Conditioning, Animal
chemical_list: D009124:Muscle Proteins; D047492:Peroxisome Proliferator-Activated Receptors; D000263:Adenylate Kinase; D002118:Calcium